KDM1A and neuroblastoma: Conversely, a high overexpression of LSD1 in many solid tumors possessing aggressive clinicopathological features, i.e., neuroblastoma, chondrosarcoma, or hepatocellular carcinoma, suggests that the enzyme can serve as an oncogene in the context of malignant transformation [24,25,26].